MDMX acidic domain inhibits p53 DNA binding in vivo and regulates tumorigenesis

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MDMX (also known as MDM4) is an oncoprotein that inhibits the tumor suppressor p53.
• The precise mechanisms by which MDMX regulates p53 activity are not fully understood.
• MDMX possesses both a canonical p53-binding domain and other domains that may influence p53 interaction.

Purpose of the Study:

• To investigate the physiological role of specific MDMX interactions with p53.
• To determine the function of the conserved WW motif within MDMX.
• To elucidate MDMX's role in p53 regulation and cancer development.

Main Methods:

• Generation of an MDMX knockin mouse model with mutations in the WW motif (W201S/W202G).
• Analysis of p53 levels, DNA binding, and target gene expression in cells from the knockin mice.
• Evaluation of tumor development and survival in Eµ-Myc transgenic mice with the mutated MDMX.

Main Results:

• MDMX-deficient cells exhibit normal p53 levels but increased p53 DNA binding and target gene expression, leading to senescence.
• The mutated MDMX inhibited early-stage Eµ-Myc-driven disease but accelerated lethal lymphoma onset and reduced survival.
• The WW motif of MDMX plays a dual role in regulating p53 and suppressing Myc-driven lymphomas independently of p53.

Conclusions:

• MDMX is a critical regulator of p53 DNA binding, distinct from MDM2's role in p53 stabilization.
• The MDMX WW motif is essential for its tumor-suppressive functions.
• Targeting MDMX interactions could offer new therapeutic strategies for lymphomas.